Cargando…
MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
Alzheimer’s disease (AD) is the most common age-related, progressive neurodegenerative disease. It is characterized by memory loss and cognitive decline and responsible for most cases of dementia in the elderly. Late-onset or sporadic AD accounts for > 95% of cases, with age at onset > 65 year...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301178/ https://www.ncbi.nlm.nih.gov/pubmed/30531004 http://dx.doi.org/10.4103/1673-5374.244784 |
Ejemplares similares
-
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations
por: Martinez, Bridget, et al.
Publicado: (2020) -
MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury
por: Martinez, Bridget, et al.
Publicado: (2017) -
MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022) -
Blood microRNAs as potential diagnostic markers for hemorrhagic stroke
por: Martinez, Bridget, et al.
Publicado: (2017)